• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci USA. Prospects of elimination of HIV with test-and-treat strategy

Giuseppe

Emeritus
[Source: Proceedings of the National Academy of Sciences of the United States of America, full page: (LINK). Abstract, edited.]


Prospects of elimination of HIV with test-and-treat strategy


Mirjam E. Kretzschmar<SUP>a</SUP>,<SUP>b</SUP>,<SUP>1</SUP>, Maarten F. Schim van der Loeff<SUP>c</SUP>,<SUP>d</SUP>, Paul J. Birrell<SUP>e</SUP>, Daniela De Angelis<SUP>e</SUP>, and Roel A. Coutinho<SUP>a</SUP>,<SUP>b</SUP>
<SUP></SUP>
Author Affiliations: <SUP>a</SUP>Centre for Infectious Disease Control, National Institute of Public Health and the Environment, 3721MA, Bilthoven, The Netherlands; <SUP>b</SUP>Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, 3584CX, Utrecht, The Netherlands; <SUP>c</SUP>Department of Infectious Disease Control, Public Health Service Amsterdam, 1018WT, Amsterdam, The Netherlands; <SUP>d</SUP>Center of Infection and Immunity Amsterdam, Academic Medical Center, 1105AZ, Amsterdam, The Netherlands; and <SUP>e</SUP>Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, Cambridge CB2 0SR, United Kingdom

Edited by Burton H. Singer, University of Florida, Gainesville, FL, and approved August 8, 2013 (received for review February 1, 2013)


Abstract

Recently, there has been much debate about the prospects of eliminating HIV from high endemic countries by a test-and-treat strategy. This strategy entails regular HIV testing in the entire population and starting antiretroviral treatment immediately in all who are found to be HIV infected. We present the concept of the elimination threshold and investigate under what conditions of treatment uptake and dropout elimination of HIV is feasible. We used a deterministic model incorporating an accurate description of disease progression and variable infectivity. We derived explicit expressions for the basic reproduction number and the elimination threshold. Using estimates of exponential growth rates of HIV during the initial phase of epidemics, we investigated for which populations elimination is within reach. The concept of the elimination threshold allows an assessment of the prospects of elimination of HIV from information in the early phase of the epidemic. The relative elimination threshold quantifies prospects of elimination independently of the details of the transmission dynamics. Elimination of HIV by test-and-treat is only feasible for populations with very low reproduction numbers or if the reproduction number is lowered significantly as a result of additional interventions. Allowing low infectiousness during primary infection, the likelihood of elimination becomes somewhat higher. The elimination threshold is a powerful tool for assessing prospects of elimination from available data on epidemic growth rates of HIV. Empirical estimates of the epidemic growth rate from phylogenetic studies were used to assess the potential for elimination in specific populations.

HIV elimination - mathematical model - primary HIV infection - treatment coverage


Footnotes

<SUP>1</SUP>To whom correspondence should be addressed. E-mail: mirjam.kretzschmar@rivm.nl.

Author contributions: M.E.K. and M.F.S.v.d.L. designed research; M.E.K. and M.F.S.v.d.L. performed research; P.J.B. and D.D.A. contributed analytic tools; M.E.K., M.F.S.v.d.L., P.J.B., and D.D.A. analyzed data; and M.E.K., M.F.S.v.d.L., P.J.B., D.D.A., and R.A.C. wrote the paper.

The authors declare no conflict of interest.

This article is a PNAS Direct Submission.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1301801110/-/DCSupplemental.


-
-------
 
Back
Top